Cramer's 'Mad Money' Recap: The Next Great Diagnostics Play

The first name on Cramer's Benefit of the Doubt list on Monday was VF Corp.'s (VFC Quote) Mackey McDonald.

When people wanted VF to get rid of its Vanity Fair bra business, it did, Cramer said. Instead of going up after that, the stock suffered. But now, a month later, the stock is up significantly, he said.

"This man is a man I can trust," he said. "When VF misses a number, you can take it as a buying opportunity."

Activists and Underperformers

The new template is that an underperforming management plus an activist investor equals money, Cramer said. A stock that fits this model and one that investors should consider getting into is PDL BioPharma (PDLI Quote).

The company gets millions of dollars in royalties, but people wouldn't know that from the performance of its stock. PDL BioPharma's management has made "many bad decisions" over the years and turned the company into something people don't want to touch with a 10-foot pole, Cramer said.

But now that credible activists have moved in and have estimated that the $20 stock should reach $39 to $59, he believes it is time for viewers to get in as well. The activists will be doing the "heavy lifting" here to get the management to start acting more intelligently, and all that market-players have to do is "piggyback" off that, Cramer said.